Arpeggio Biosciences
PrivateLast Round
Series B
Nov 25, 2025
Est. Valuation
$2.14M
Total Funding Raised
$24.38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arpeggio Biosciences is a biotechnology company that develops a drug assessment technology platform combining proprietary biological assays and machine learning to provide insights into cellular dynamics and identify new drug targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arpeggio Biosciences Comparables
Compare Arpeggio Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 84% | |
| Phenomic AI | 79% | |
| Alithea Genomics | 77% |
Arpeggio Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 25, 2025 | ||||
| Series A Extension | Jan 30, 2024 | ||||
| Series A | Sep 7, 2022 | ||||
| Seed | Jan 15, 2020 | ||||
| Accelerator | Aug 16, 2019 |
Key People
Founding team and executive leadership
Arpeggio Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Builders VC | Series A |
| Khosla Ventures | Series A, Seed |
| Tau Ventures | Series A |
| BoxOne Ventures | Series A |
| Y Combinator | Seed, Accelerator |
| FundersClub | Series A, Seed |
| ATEM Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 55% MoM, from 1.3K to 2K.
- Jul 26, 2026
Monthly visitors increased 214% MoM.
Arpeggio Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arpeggio Biosciences's valuation, stock price, and market status.
Is Arpeggio Biosciences a public or private company?
Arpeggio Biosciences is a private company.
What is the current stock price of Arpeggio Biosciences?
Arpeggio Biosciences is a private company, so its shares have no public market price. Caplight tracks Arpeggio Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arpeggio Biosciences worth (valuation)?
Arpeggio Biosciences's valuation is estimated at $2.1M based on funding round data.
Can I buy Arpeggio Biosciences stock?
Arpeggio Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arpeggio Biosciences's last funding round?
Arpeggio Biosciences's most recent funding round was Series B on November 25, 2025.
Who are the main investors in Arpeggio Biosciences?
Key investors in Arpeggio Biosciences include Builders VC, Khosla Ventures, Y Combinator.
Will Arpeggio Biosciences IPO soon?
No public IPO plans have been announced for Arpeggio Biosciences.
How can I track Arpeggio Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Arpeggio Biosciences's shares on secondary markets.